Corneal Neurotization

The cornea is one of the most densely innervated tissues in the human body, supplied primarily by the ophthalmic branch of the trigeminal nerve (cranial nerve V). These nerves provide sensation and reflexes essential for corneal health, such as blinking, tear production, and wound healing.

When the trigeminal nerve or its branches are damaged—due to trauma, viral infections (like herpes zoster ophthalmicus), neurosurgery, or tumors—the cornea loses its sensory input. This loss leads to neurotrophic keratopathy, characterized by reduced corneal sensation, epithelial breakdown, ulceration, and potential perforation.

Conventional treatments such as lubricating drops, tarsorrhaphy (partial eyelid closure), or amniotic membrane grafts only provide surface protection and symptomatic relief. They do not address the underlying problem—the absence of corneal nerves.

What is Corneal Neurotization?

Corneal neurotization involves transferring healthy donor nerves from other regions of the body or the opposite eye to the cornea, allowing the growth of new nerve fibers into the anesthetic cornea. This procedure can be performed through direct or indirect techniques, depending on the site and extent of nerve damage.

The principle is to provide a new source of innervation by connecting functioning sensory nerves to the corneal stroma, enabling axonal regeneration and restoration of corneal sensation.

Indications for Corneal Neurotization

Corneal neurotization is indicated in patients with neurotrophic keratopathy due to:

• Trigeminal nerve injury
• Herpes zoster ophthalmicus
• Neurosurgical procedures (e.g., acoustic neuroma removal)
• Tumors or trauma involving the orbit or skull base
• Congenital corneal anesthesia
• Post-infectious or iatrogenic nerve damage
• Persistent epithelial defects or ulcers unresponsive to conventional therapy

Early intervention is crucial, as prolonged corneal anesthesia leads to scarring, thinning, and irreversible visual loss.

Types of Corneal Neurotization

Corneal neurotization can be classified into two main techniques: direct and indirect.

1. Direct Corneal Neurotization

In direct neurotization, a functioning sensory nerve—typically a branch of the supraorbital or supratrochlear nerve from the same or opposite side—is directly transferred and sutured near the anesthetic cornea. The nerve is tunneled through the eyelid and anchored near the limbus (edge of the cornea).

This approach provides immediate proximity for nerve regeneration, often leading to faster recovery of sensation. It is suitable when the donor nerve is anatomically close to the affected cornea.

2. Indirect Corneal Neurotization

When direct nerve transfer is not feasible, nerve grafts are used to bridge the gap between a distant donor nerve and the cornea. Common donor nerves include the sural nerve (from the leg) or great auricular nerve (from the neck).

The harvested nerve graft is connected microsurgically to a functional sensory nerve (e.g., supraorbital or infraorbital nerve) and tunneled to the cornea. Axons then regenerate along the graft and eventually reinnervate the corneal tissue. This technique, while more complex, expands the range of patients who can benefit from the surgery.

Surgical Procedure

Corneal neurotization is performed under microsurgical guidance using delicate instruments and high magnification.

• Anesthesia and Preparation The patient is placed under local or general anesthesia depending on the complexity. Donor and recipient sites are prepared and sterilized.
• Identification of Donor Nerve A suitable sensory nerve (e.g., supraorbital, supratrochlear, or infraorbital) is identified and exposed.
• Harvesting Nerve Graft (Indirect Technique) If an indirect approach is used, a segment of the sural nerve (commonly 20–30 cm) is harvested from the leg. The graft is preserved in saline solution until implantation.
• Tunneling and Fixation A subcutaneous tunnel is created across the face to route the graft from the donor site to the cornea. The distal ends of the graft are carefully positioned around the limbus and fixed within the conjunctiva or sclera.
• Microsurgical Coaptation The proximal end of the graft is sutured to the donor nerve using micro sutures or fibrin glue. This connection allows axons from the donor nerve to grow through the graft into the corneal region.
• Closure and Recovery Incisions are closed meticulously to minimize scarring. Postoperative dressings and medications are applied to reduce inflammation and infection.

Postoperative Care and Recovery

• Topical antibiotics and steroids to prevent infection and control inflammation.
• Lubricating drops to maintain corneal hydration during the healing phase.
• Follow-up visits with corneal sensitivity tests, slit-lamp examination, and imaging to monitor nerve regeneration.

Corneal sensitivity typically begins to return within 3 to 6 months, with gradual improvement over a year. The restored nerves also promote epithelial healing, reducing the risk of recurrent ulcers and scarring.

Benefits of Corneal Neurotization

• Restores corneal sensation, enabling natural reflexes like blinking and tear secretion.
• Promotes corneal healing and epithelial stability.
• Prevents vision loss by protecting against ulceration and scarring.
• Offers durable recovery of corneal health and transparency, reducing long-term dependence on artificial tears and protective procedures.

Potential Risks and Complications

• Donor site numbness — usually mild and temporary.
• Scarring or asymmetry from incisions.
• Incomplete or delayed reinnervation in some cases.
• Infection or graft failure, which is uncommon with appropriate care.

Success and Outcomes

Clinical studies have demonstrated that corneal neurotization effectively restores corneal sensitivity and improves ocular surface integrity. Objective measures, including Cochet-Bonnet esthesiometry and in vivo confocal microscopy, confirm reinnervation of corneal tissue within months after surgery. Most patients experience healing of corneal ulcers, improved epithelial stability, and reduced dependency on artificial tears.